chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reoccurrence of lung cancer; This is a spontaneous report from a contactable consumer (friend).  A female patient of an unspecified age received BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history included lung cancer. Concomitant medications were not reported. The consumer reported that her friend (the patient) got the vaccine and had a reoccurrence of lung cancer on unspecified date, in which she was told would not happen. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Pt. states that after receiving the 2nd dose of Pfizer on 03/18/2021, started experiencing pain in the right shoulder immediately after. Still continuing.
headache; dizziness; swelling on entire arm; This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. A 16-year-old male patient received meningococcal group b rlp2086 (TRUMENBA, lot number and expiration date unknown), via an unspecified route of administration in the right arm on 17Apr2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On the same day, 17Apr2019, the patient experienced headache, dizziness and swelling on entire arm. The patient's mother took him to the emergency room on 17Apr2019. No action was taken at the ER. The patient returned to the doctor the next day. He was feeling better and the symptoms had decreased. The outcome of the events was recovering.  No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.
Client got out of bed and felt dizzy. Got a cigarette and coffee. Thirty minutes later felt "Loopy, weak, loose). Stomach started to feel nauseated and uncomfortable went to bathroom and had loose stool. States had 3 loose stools yesterday and has had no loose stools today. States he has not had a fever, but feels bad. On September 16th at about 9:00n PM got up to urinate and felt really cold while in the bathroom. Went back to couch with chills and a minute later got very hot. Within 2-3 minutes it was oer and the episode has not been repeated.
skin felt tender and itchy; skin felt tender and itchy; This spontaneous case was reported by a physician and describes the occurrence of PAIN OF SKIN (skin felt tender and itchy) and PRURITUS (skin felt tender and itchy) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for an unknown indication.    No medical history was provided by the reporter.    In 2020, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-May-2021, the patient experienced PAIN OF SKIN (skin felt tender and itchy) and PRURITUS (skin felt tender and itchy). At the time of the report, PAIN OF SKIN (skin felt tender and itchy) and PRURITUS (skin felt tender and itchy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were provided.
6hr post rt thigh DTP/HIB site red (dime sized) then small pseudopod extension;12hr later temp 101R & gen giant urticaria;tx atarax, prelone & duricef;48hr later break through angioedema tx inc;72hr post temp 100 & hives gone but bruise;
As described by mother. Pt developed a single "hive" where ENGERIX-B was given on 6/13/13. Reports "hive" was noticed at 1pm on 6/14/13 on (L) outer thigh; approximate size of a quarter red and warm. Mom denies opening or drainage. Mother continues to observe. No treatment given.
Information has been received from a physician concerning a patient who on an unknown date was vaccinated with a second dose of VARIVAX (Oka/Merck). On an unspecified date, 10 days post vaccination, the patient developed a rash. The rash was found to be positive for the vaccine strain VZV by PCR performed at the CDC. At the the time of the report the patient's status was unknown. A product quality complained was not involved. The reporting physician stated she believes there has been an increase in the frequency of calls to the local health department regarding second dose AEs, particularly rashes in patients who have received a second dose of VARIVAX (Oka/Merck). She indicated that other physicians in the region also felt they were seeing an increase in second dose rashes as compared to what they observed following the first dose. With respect to specific types of AEs, the physician stated she saw reports of generalized rashes, injection site reactions and cellulitis. She has spoke with the reporting healthcare providers and all doses of VARIVAX (Oka/Merck) were stored and administered appropriately, and all patients involved were normal healthy children. This is one of several reports received from the same source. Additional information has been requested.
Times are approx. 0845 - Flu vaccine administered in right upper arm. 0905 - Lightheaded/dizzy, voice very hoarseness. 0907 - Nauseous, hives starting. 0910 - Told nurse was getting ill, started itching due to hives, knew what I wanted to say but could not talk properly. Tongue felt swollen. 0915 - Wheel chaired by nurse to ER. 0920 - Skin observed by doctor - red, blood pressure high, incoherent, confused. 0925 - Benadryl administered thru IV, fell asleep. 1230 PM - ER released me - still felt ill and confused, hives continued for 2 days, muscles very sore, very weak.
Missed second Dose ( beyond day 35); Fever 102.4 F; Soreness of the right arm; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second Dose ( beyond day 35)), PYREXIA (Fever 102.4 F) and MYALGIA (Soreness of the right arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Cancer few years back). Concomitant products included AMLODIPINE, LEVOTHYROXINE, ASPIRIN [ACETYLSALICYLIC ACID], OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA), BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE), ZOLPIDEM TARTRATE (AMBIEN), ONDANSETRON (ZOFRAN [ONDANSETRON]) and RANITIDINE HYDROCHLORIDE (ZANTAC) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced MYALGIA (Soreness of the right arm). On 06-May-2021, the patient experienced PYREXIA (Fever 102.4 F). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second Dose ( beyond day 35)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second Dose ( beyond day 35)) and MYALGIA (Soreness of the right arm) had resolved and PYREXIA (Fever 102.4 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Body temperature: 102.4 (High) Fever of 102.4 F. On an unknown date, COVID-19: negative (Negative) Covid-19 test was done and report came negative..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was temporarily withheld on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list also included Rheo inhaler. Treatment information was not provided. Patient reported that she had a fever of 102.4 F when she went for the scheduled second dose on 6th May 2021, so vaccination facility did not administer the second dose.
Narrative:  04/14/22 Per nursing primary care note, pt received first dose of Shingrix vaccine 04/16/22 Per ambulatory secure messaging, pt reports a worsening rash that started to show up on 04/15 04/17/22 Per ambulatory secure messaging, pt reports rash is not getting better but has been using hydrocortisone cream which helped with minor discomfort 04/18/22 Per ambulatory secure messaging, pt sent an image of the rash and provider responded stating that it appears the pt is having an allergic reaction to the vaccine; recommended to take OTC Benadryl and if the rash does not resolve to seek evaluation at an ER 04/20/22 Per ambulatory secure messaging, pt reports most of his arm is red and itchy but not "too itchy" 04/21/22 Per ambulatory secure messaging, pt confirms he is still taking OTC Benadryl 04/22/22 Per ambulatory secure messaging, pt reports little red blotches on leg with mild itching but does not hurt 04/25/22 Per interim ambulatory care note, rash is resolving and flaky dry skin remains over arms; no sx of swelling, SOB, or respiratory distress
Extreme body aches; Headache; Fever; Nose burning; Memory trouble; Confusion; Lethargic; Burning eyes; Shortness of breath; Sore arms; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the left arm on 01Apr2021 at 11:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic cellulitis, fibromyalgia, chronic sinusitis, chronic bronchitis, achromobacter infection, prior septic shock, brain surgeries, breast reconstruction, staphylococcal infection (staph infections), stroke and sulphonamide allergy (sulfa allergy). Concomitant medications included ceftriaxone sodium (ROCEPHIN) taken on 15Mar2021 in the right hip for an unspecified indication, ceftriaxone sodium (ROCEPHIN) taken on 16Mar2021 in the left hip for an unspecified indication and amoxicillin sodium; clavulanate potassium (AUGMENTIN) 500 milligrams taken from an unknown date for an unknown indication. The patient previously received PAXIL, EFFEXOR, TOPIMAX, CYMBALTA and morphine and experienced a drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021, the patient experienced fatigue. On 02Apr2021, the patient experienced worsened fatigue and sore arms in the evening. On 03Apr2021 at 07:00, the patient experienced worsened fatigue, extreme body aches, a headache which was 7 on the pain scale that did not respond to medications, fever, nose burning, memory trouble, confusion, lethargic, burning eyes and shortness of breath. The patient reported that these events continued on the fourth day which was 04Apr2021. The patient reported that on 05Apr2021, the fifth day the patient still was fatigued and weak but there was some improvement. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/ department or urgent care. The patient did not receive any treatments for the events experienced except for headache for which she took unspecified medications. The clinical outcome of the events fatigue, sore arms, body ache, headache, fever, nose burning, memory trouble, confusion, lethargy, burning eyes and shortness of breath were resolved with sequelae on an unspecified date in Apr2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
The Patient and his twin sister both fainted after getting TDaP and MENACTRA. Both patients remained in our office for 20 min after episode. We elevated their legs, used cool compresses and gave cup of water. Vital signs taken and normal. Both patients recovered quickly and left office without incident 20 min later. Follow up phone call placed to father 4 hours later, father report both kids went home and took a nap. They ate lunch and are drinking fluids well. No further issues with dizziness or nausea. Off note today is a very hot/humid day, area is under heat advisory.
6-8 hours post vax, found in crib, moving head back and forth, pupils dilated, fine tremors of extremities, lasted several hours. Less interactive during episode. No fever. Recovered in 12 hours.
0900: Rec'd Covid vaccine 0931: Pt c/o dizzy/light-headed, sweaty in car 0937: BP 116/78 HR 60 RR 16 SpO2 98%  Drinking water/juice; opened car windows/door; lying down in car 0942: Left arm from neck down feels hot inside; less light-headed/dizzy & sweaty 0956: Still feeling lightheaded, resting in car w/HOB down
I felt these symptoms around 7:30 PM. Chills, fainting, hard time breathing, diarrhea and my body went numb. It is day five since I got the shot, and I have chills. And upset stomach.
Patient feels nauseous and weak. Medic present,  Vital WNL BP 122/68, HR 88, )2 98%
SEVERAL SMALL PATCHES OF HIVES, NON SPREADING, TREATED WITH BENADRYL ORAL
My left shoulder was sore as expected. In the coming weeks, the pain extended down my deltoid and to my elbow. I was and still am unable to lift my left arm higher than shoulder level without pain. I visited my doctor who referred me to PT. I attended several sessions and did exercises  and icing at home, but my left arm is still sore, now  over 6 months later.
left arm sore; left arm has a large lump like a 50 cent piece; left arm itching; This is a spontaneous report from a contactable consumer (patient reported herself). A 75-year-old female patient received BNT162B2 (Pfizer Covid shot, Formulation: Solution for injection, Batch/lot number: Not Provided, Expiry Date/NDC number: Not Provided) via an unspecified route of administration on 25Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced left arm sore, left arm has a large lump like a 50 cent piece and left arm itching. Caller stated that she received her first shot on 25Jan2021 and that her arm was sore which went away in a few days. Stated that she received the second shot early on 09Feb2021 because she was scheduled to have surgery. Stated that the spot where she received it is sore, has a large lump like a 50 cent piece and is itching. Stated that she went to the doctor and he put her on Benadryl and Zyrtec over the counter for allergies. Wanted to know if it will be safe to go and have surgery if she had this going on. Stated it was sore and she had terrible itching. Wanted to know if she was on the right track. Stated that she would start testing for surgery on Monday. Wanted to know Pfizer's opinion and if had others are calling with same. Clarified that it was for the left arm for both shots. Clarified that it was for Pfizer Covid shot. Outcome of the events was unknown.  Information about lot/batch number has been requested.
Overnight experienced fever, chills, fatigue. In morning experienced fatigue, lightheadedness, headache, and nausea
Fatigue, joint and muscle soreness - lasted for a little over 48 hours Injection site reaction on left arm - began a few hours after injection and continued to spread. As of 2/19/21 at 3:30pm, has grown to the size of an index card. Feels sore, warm and firm.
received Shingrix second dose half of final volume; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number 7F94C, expiry date 11th November 2022) for prophylaxis.   On 28th April 2021, the patient received the 2nd dose of Shingrix .25 ml. On 28th April 2021, unknown after receiving Shingrix, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown.  Additional details were provided as follows: The pharmacist reported that the patient received Shingrix 2nd dose half of final volume (0.25ml approximately) due to problem with needles which lead to accidental underdose. The reporter consented to follow up. The pharmacist asked to receive a follow-up on the patient to her private phone as soon as possible.
Pt had large hive present at vaccine site. Pt c/o generalized achiness; seen in office 9/5/14. BENADRYL, cold compress advised for tx.
Patient c/o 2 days expanding redness to upper extremity, itchiness, warm to touch at the site, and firmness to the area. Evaluated on 6 Dec in clinic patient was given Topical BENADRYL and MOTRIN for symptom control.
Pt. reported injection site soreness following immunization around 11AM on 6/26/13. Pt. experienced chills, achy all over, weak "hard to get up", felt feverish but no documented temperature measured, loss of appetite.
pt recvd vax; red, warm, swollen upper arm lasting 2 days;
Pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 38-year-old female patient (gravida 4) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021 at 2:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 05-Nov-2020 and the estimated date of delivery was 12-Aug-2021. On 20-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  tenth week of the pregnancy.  On 20-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Dec-2020, Pregnancy test: positive (Positive) Positive. In January 2021, Ultrasound scan: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had three previous pregnancies.  For first pregnancy, end of pregnancy was in 2004, which resulted in induced abortion.  For second pregnancy, end of pregnancy was in 2005, which resulted in induced abortion.  For third pregnancy, end of pregnancy was in 2006, which resulted in induced abortion.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
p/vax pt cried continuously x 3 hrs got quiet by riding in car; had low grade fever mom gave APAP; had rash 2nd afternoon & 3rd day on body;
Pt recvd vax & 2 days later exp mild rash & hives; no treatment given;
This is an administration error. The patient received his first COVID-19 vaccine 5/24/21. We missed calculated and gave him his second shot on 6/14/21 instead of 6/21/21. The Moderna hotline was called and the patient was notified. The patient did not experience any side effects.
Pt vaxd w/3 doses of Hep B, 1st dose 16FEB90 & 3rd dose 24AUG90; pt noted was pregnant 21JUL90 & underwent C-section (WAES91020545) because was noted during labor umbilical cord was around baby's neck; dec dilation & baby not descending;
This spontaneous report as received from a health care worker refers to an unspecified number of patients of unknown age and gender. No concurrent conditions or medical history were reported. The reporter stated that since 16-JUN-2015, the patients were vaccinated with doses of RECOMBIVAX HB (Lot # K020216, expiration date 17-SEP-2016; Lot # K016005, expiration date 27-AUG-2016) (doses and route were not specified), which were exposed to temperatures outside of the recommended range on 16-JUN-2015. No concomitant medications were reported. No adverse experience has been observed or reported. This is one of several reports from the same source. Additional information has been requested.
Patient fainted slightly after administration of FLUZONE 2011-12 vaccine. She was later conscious again and all vitals (verified by paramedic) are fine. Patient was followed up by doctor.
A report has been received from a Health Professional concerning a 53 year old, Female subject, who had been receiving FLUMIST quadrivalent, (intranasal), 0.2 Millilitres. FLUMIST quadrivalent started on an unknown date for Influenza. FLUMIST was administered to 53 year old female patient. The outcome of the event of outside indicated range is unknown. The report was considered to be non-serious.
Swelling at injection site a few hours after injection then erythema the morning after, which was 24 hours.
This case was reported by a physician and described the occurrence of arm soreness in a 8 year old male subject who was inadvertently vaccinated with Fluarix for prophylaxis. Previous history of arm soreness with other influenza vaccinations. On 07 November 2006 the subject received Fluarix .5 ml and experienced a sore arm and inadvertently vaccination with Fluarix. Fluarix is recommended for immunizing individuals 18 years and older. Further information was not known.
rash on the front part of your arm; Extreme fatigue; itchiness; Burning rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on the front part of your arm), FATIGUE (Extreme fatigue), PRURITUS (itchiness) and SKIN BURNING SENSATION (Burning rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included VITAMINS NOS for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH (rash on the front part of your arm), FATIGUE (Extreme fatigue), PRURITUS (itchiness) and SKIN BURNING SENSATION (Burning rash). At the time of the report, RASH (rash on the front part of your arm) was resolving and FATIGUE (Extreme fatigue), PRURITUS (itchiness) and SKIN BURNING SENSATION (Burning rash) outcome was unknown.            No concomitant medication was provided.  No treatment details were provided.
+ swelling, + redness to left deltoid since 11/21/04. DTAP and IPC given to area on 11/20/04. Was advised by physician Benadryl and Keflex 250/5 1tsp po q 8 hours  x 70 mg prn
Small 1 cm area of erythema at site of right lateral thigh where previous injection administered three days after vaccine. Area of erythema has persisted, but non-tender. No treatment indicated at this time.